The Association of Body Mass Index with COVID-19 Complications and Survival Rate at a Tertiary Hospital
暂无分享,去创建一个
Amal Alzahrani | A. Aldhahir | J. Alqahtani | Yaser A. Al Naam | A. Alqahtani | M. Bakkar | Thekra N. Al-maqati | S. Alrabeeah | S. AlBahrani | Rawan M Maawadh | F. Alkhalaf | Hind R. Alzuraiq | Maryam Hamad Alenezi | Zainab Albahrani | Rawan M. Maawadh | Y. A. Al Naam | Faisal Alkhalaf | M. Alenezi
[1] M. Zangeneh,et al. Survival analysis based on body mass index in patients with Covid-19 admitted to the intensive care unit of Amir Al-Momenin Hospital in Arak – 2021 , 2022, Obesity Medicine.
[2] O. Cronie,et al. BMI, sex and outcomes in hospitalised patients in western Sweden during the COVID-19 pandemic , 2022, Scientific Reports.
[3] M. Al-Hariri,et al. The impact of obesity on hospitalized patients with COVID-19 infection in the Eastern Province of Saudi Arabia , 2022, Journal of Medicine and Life.
[4] C. Rylander,et al. Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study , 2021, PloS one.
[5] Hyunggoo Kang,et al. The effect of BMI on COVID-19 outcomes among older patients in South Korea: a nationwide retrospective cohort study* , 2021, Annals of medicine.
[6] A. Sheikh,et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study , 2020, BMJ.
[7] Yan-Mei Huang,et al. Obesity in patients with COVID-19: a systematic review and meta-analysis , 2020, Metabolism.
[8] H. Alwafi,et al. Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: An Ecological Study , 2020, Frontiers in Public Health.
[9] B. Popkin,et al. Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[10] K. Khunti,et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.
[11] C. Pedone,et al. Computed Tomography Highlights Increased Visceral Adiposity Associated With Critical Illness in COVID-19 , 2020, Diabetes Care.
[12] H. Rusinek,et al. Visceral adipose tissue in patients with COVID-19: risk stratification for severity , 2020, Abdominal Radiology.
[13] I. Pavord,et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people , 2020, Heart.
[14] L. Strigari,et al. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 , 2020, Metabolism.
[15] P. Hegyi,et al. Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[16] F. C. Stanford,et al. Outcomes of COVID-19: disparities in obesity and by ethnicity/race , 2020, International Journal of Obesity.
[17] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.
[18] S. Barquera,et al. The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients , 2020, Obesity.
[19] J. Hewitt,et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study , 2020, The Lancet Public Health.
[20] S. O’Rahilly,et al. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? , 2020, Med.
[21] J. Pell,et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[22] Feng Gao,et al. Obesity Is a Risk Factor for Greater COVID-19 Severity , 2020, Diabetes Care.
[23] J. Sterne,et al. Collider bias undermines our understanding of COVID-19 disease risk and severity , 2020, Nature Communications.
[24] R. Carmona,et al. Failing Another National Stress Test on Health Disparities. , 2020, JAMA.
[25] W. Dietz,et al. Obesity and its Implications for COVID‐19 Mortality , 2020, Obesity.
[26] Lanjuan Li,et al. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19) , 2020, Journal of internal medicine.
[27] M. He,et al. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV]. , 2020, Zhonghua xin xue guan bing za zhi.
[28] A. Pesenti,et al. Pathophysiology and Management of Acute Respiratory Distress Syndrome in Obese Patients , 2019, Seminars in Respiratory and Critical Care Medicine.
[29] D. van der A,et al. The Association Between BMI and Different Frailty Domains: A U-Shaped Curve? , 2018, The journal of nutrition, health & aging.
[30] He Yu,et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis , 2017, Critical Care.
[31] S. Lemeshow,et al. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury* , 2006, Critical Care Medicine.
[32] A. Aljahdali,et al. The prevalence of obesity in hospitalized COVID-19 patients at King Abdullah Medical City, Makkah, Saudi Arabia , 2021, International Journal of Medicine in Developing Countries.